Opdualag for metastatic melanoma.

doi:10.58347/tml.2023.1668g

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Opdualag for metastatic melanoma.

The Medical letter on drugs and therapeutics - 23 Jan 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Melanoma
Share to Mutation
Share to Proto-Oncogene Proteins B-raf

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Skin Neoplasms

Source

Open in PubMed

Identifiers

PMID: 36651796
DOI: 10.58347/tml.2023.1668g

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Opdualag for metastatic melanoma.PMID 36651796Read ↗

The pathway ahead in melanoma trials.Semantic proximity Read ↗

[Guidelines for stage I to III melanoma].Semantic proximity Read ↗

Melanoma as a model for precision medicine in oncology.Semantic proximity Read ↗

Melanoma's next top model, it is in the air.Semantic proximity Read ↗

Conjunctival Melanoma: Current Treatments and Future Options.Semantic proximity Read ↗

Nivolumab (Opdivo) plus ipilimumab (Yervoy) for metastatic melanoma.Semantic proximity Read ↗

[Paradigmatic shift in oncology: individualized melanoma treatment].Semantic proximity Read ↗

Current management of melanoma.Semantic proximity Read ↗

[Melanoma and search for therapeutic targets].Semantic proximity Read ↗

A step forward for patients with NRAS-mutant melanoma.Semantic proximity Read ↗

Targeting activated KIT signaling for melanoma therapy.Semantic proximity Read ↗

Talimogene laherparepvec (Imlygic) for unresectable melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.